October 26, 2026

Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development

Lunit and Summit Therapeutics: Research Will Use Lunit’s AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment Biology  Seoul, South Korea and Miami, Florida, October 23, 2026 – Lunit Inc....

recent articles

Thursday, 18th February 2016 | Europe  4.00 – 5.00pm GMT | USA 4.00 – 5.00pm EST PathXL’s educational solution supports the combination of digital pathology with other multimedia and content creation capabilities to provide a rich...

microDimensions, software and service provider for digital pathology image analysis solutions, recently launched Slidematch™, the one-of-a-kind software for the alignment of differently stained brightfield sections in full resolution....

The Paris-Sud University Hospital Consortium is comprised of three hospitals: Antoine-Béclère, Bicêtre and Paul-Brousse. These hospitals provide a wide variety of specialized medical and surgical services for children and adults, with a...

Quantitative nucleic features are effective for discrimination of intraductal proliferative lesions of the breast Masatoshi Yamada, Akira Saito, Yoichiro Yamamoto, Eric Cosatto, Atsushi Kurata, Toshitaka Nagao, Ayako Tateishi, Masahiko Kuroda J...

According to GuideStar.org, The American Registry of Pathology (ARP) was founded in 1921 and chartered by the United States congress in 1976 to serve the American people as a focus for the interchange of knowledge between military and civilian...

Interesting article by Kathy Liszewski over at Genetic Engineering and Biotechnology News looking at circulating tumor cells (CTCs) incorporated with digital pathology. There is little doubt in my mind that technologies involving CTCs,...

OR

platinum partners

gold partners

Silver Partners

Media Partners